Conmed Corp

Research Conmed Corp (CNMD) on Bullrun: valuation model: 10.3% overvalued, market cap USD 1.53B, P/E 27.7, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerCNMD
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
Valuation signal10.3% overvalued
Market capUSD 1.53B
P/E27.7
Dividend yield0.4%
Financial periodQ2 2026
RevenueUSD 343.49M
Net incomeUSD 23.07M
Free cash flowUSD 34.16M
Gross margin57.5%

Valuation Snapshot

Bullrun's latest valuation model marks Conmed Corp as 10.3% overvalued; latest market cap is USD 1.53B; P/E is 27.7; dividend yield is 0.4%.

Peer valuation comparison

Latest P/E is 27.65x versus a Healthcare sector median of 24.46x (13.0% above).

Latest dividend yield is 0.4% versus a Healthcare sector median of 2.11% (81.0% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 1.37B	USD 47.10M	USD 150.88M	54.6%	1.51	USD 40.82M	USD 834.94M	USD 1.03B
FY2024	USD 1.31B	USD 132.40M	USD 153.88M	56.1%	4.25	USD 24.46M	USD 905.78M	USD 962.68M
FY2023	USD 1.24B	USD 64.50M	USD 106.32M	54.3%	2.04	USD 24.30M	USD 973.85M	USD 834.22M
FY2022	USD 1.05B	-USD 80.60M	USD 11.58M	54.6%	-2.68	USD 28.94M	USD 982.70M	USD 745.55M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 1.53B	27.7	0.4%	0.2
2025	2025-12-31	USD 1.26B	26.7	1.5%	0.6
2024	2024-12-31	USD 2.11B	16.1	1.2%	0.8
2023	2023-12-29	USD 3.37B	59.2	0.7%	0.8
2022	2022-12-30	USD 2.70B	n/a	0.9%	0.8
2021	2021-12-31	USD 4.16B	73.5	0.6%	0.8

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.2 USD, yield 0.4%.

Year	Dividends/share
FY2025	0.6 USD
FY2024	0.8 USD
FY2023	0.8 USD
FY2022	0.8 USD

About Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

ESTABLISHMENT LABS HLDGS (3E0) Senseonics Holdings Inc. (6L60) Abbott Laboratories (ABT) Adagio Medical Holdings Inc (ADGM) Aethlon Medical Inc (AEMD) AdaptHealth Corp (AHCO) Alamar Biosciences, Inc. (ALMR) Allurion Technologies Inc (ALUR) Autonomix Medical Inc (AMIX) Artivion Inc (AORT) AOTI Inc (AOTI) Apyx Medical Corp (APYX)

Frequently asked questions

Is Conmed Corp overvalued or undervalued?

Bullrun's valuation model currently marks Conmed Corp as 10.3% overvalued.

What is Conmed Corp's market cap?

Conmed Corp's market capitalization is USD 1.53B.

What is Conmed Corp's P/E ratio?

Conmed Corp's price-to-earnings (P/E) ratio is 27.7.

Does Conmed Corp pay a dividend?

Conmed Corp has a dividend yield of 0.4%.

What does Conmed Corp do?

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.